The American public deserves more COVID-19 vaccine options
Covaxin, an inactivated SARS-CoV-2 vaccine and the only vaccine to have been proven effective against all variants including the Delta variant in a Phase III clinical study, deserves to be tested in clinical trials in the U.S. for potential CDC/FDA approval for use in the U.S.
As we are about to celebrate the one-year anniversary of the vaccine rollout against COVID-19, we would do well to remember that despite the progress …
The American public deserves more COVID-19 vaccine options












![Politics and fear have replaced science in U.S. pain management [PODCAST]](https://kevinmd.com/wp-content/uploads/11c2db8f-2b20-4a4d-81cc-083ae0f47d6e-190x100.jpeg)




![Finding peace and reclaiming humanity within a broken health care system [PODCAST]](https://kevinmd.com/wp-content/uploads/058307ba-bb36-43f1-9e3a-6e3100f183b5-190x100.jpeg)

